Alaunos Therapeutics, Inc.
TCRT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001107421
No open-market purchases or sales by Alaunos Therapeutics, Inc. insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $204.4K in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Alaunos Therapeutics, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 110
- −10 vs. Q4 2022
- Shares held
- 70.9M
- −6.93M (−8.9%) vs. Q4 2022
- Total value
- $44.7M
- −$5.81M (−11.5%) vs. Q4 2022
- New holders
- 7
- 25 more added
- Sold out
- 17
- 30 more reduced
4 institutions that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TCRT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 29 | $204.4K |
| Q1 2026 | 29 | $360.5K |
| Q4 2025 | 27 | $349.9K |
| Q3 2025 | 26 | $158.3K |
| Q2 2025 | 28 | $344.6K |
| Q1 2025 | 29 | $103.4K |
| Q4 2024 | 30 | $137.0K |
| Q3 2024 | 29 | $622.8K |
| Q2 2024 | 50 | $1.69M |
| Q1 2024 | 46 | $4.23M |
| Q4 2023 | 86 | $2.96M |
| Q3 2023 | 92 | $7.36M |
| Q2 2023 | 102 | $34.2M |
| Q1 2023 | 110 | $44.7M |
| Q4 2022 | 124 | $50.5M |
| Q3 2022 | 125 | $128.6M |
| Q2 2022 | 125 | $90.7M |
| Q1 2022 | 149 | $65.8M |
| Q4 2021 | 167 | $155.9M |
| Q3 2021 | 163 | $194.1M |
| Q2 2021 | 156 | $297.6M |
| Q1 2021 | 153 | $422.7M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Alaunos Therapeutics, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Boxer Capital, LLC | 1,500,000 | $945.0K | 0.05% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 1,521,392 | $958.5K | 0.00% | −416,400−21.5% | Reduced |
| Geode Capital Management, LLC | 2,136,640 | $1.35M | 0.00% | +42,302+2.0% | Added |
| JPMorgan Chase & Co | 2,517,426 | $1.59M | 0.00% | +8410.0% | Added |
| BlackRock Inc. | 5,087,649 | $3.21M | 0.00% | −345,685−6.4% | Reduced |
| Laurion Capital Management LP | 5,720,500 | $3.60M | 0.16% | 00.0% | Unchanged |
| Vanguard Group Inc | 9,155,741 | $5.77M | 0.00% | +8,000+0.1% | Added |
| MSD Partners, L.P. | 15,151,516 | $9.55M | 0.96% | 00.0% | Unchanged |
| Discovery Capital Management, LLC | 15,643,023 | $9.86M | 1.33% | −542,975−3.4% | Reduced |
| IFP Advisors, Inc | 7,738 | – | – | −9,520−55.2% | Reduced |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −500,000−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −451,698−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −141,198−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −114,131−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −82,975−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −53,320−100.0% | Sold out |
| Mirabella Financial Services LLP | 0 | $0 | 0.00% | −48,720−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −42,154−100.0% | Sold out |
| Sequoia Financial Advisors, LLC | 0 | $0 | 0.00% | −40,000−100.0% | Sold out |
| Summit Trail Advisors, LLC | 0 | $0 | 0.00% | −25,378−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −18,256−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −8,410−100.0% | Sold out |
| Madden Securities Corp | 0 | $0 | 0.00% | −4,000−100.0% | Sold out |
| GWM Advisors LLC | 0 | $0 | 0.00% | −550−100.0% | Sold out |
| Money Concepts Capital Corp | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| The PNC Financial Services Group, Inc. | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Addison Capital Co | 0 | $0 | 0.00% | −15,870−100.0% | Sold out |
| Gamble Jones Investment Counsel | – | – | – | – | Not filed |
| ARGI Investment Services, LLC | – | – | – | – | Not filed |
| Cornerstone Planning Group LLC | – | – | – | – | Not filed |
| Trustcore Financial Services, LLC | – | – | – | – | Not filed |